Literature DB >> 25612181

Spontaneous reactivation of hepatitis B virus (HBV) infection in patients with resolved or occult HBV infection.

Hiroshi Kamitsukasa1, Masanobu Iri, Akihisa Tanaka, Shigeo Nagashima, Masaharu Takahashi, Tsutomu Nishizawa, Hiroaki Okamoto.   

Abstract

Reactivation of a former hepatitis B virus (HBV) infection can be triggered by immunosuppressive therapy, diseases associated with an immunocompromised state, organ transplantation or the withdrawal of antiviral drugs. Despite the absence of such risk factors, a spontaneous reactivation of HBV replication occurred in two elderly patients with resolved or occult HBV infection. A 73-year-old male underwent coronary artery bypass grafting in October 2008, and was negative for HBsAg but positive for anti-HBs. In July 2009, his serum became positive for HBsAg, HBeAg and HBV DNA (6.4 log copies/ml; genotype C), but negative for anti-HBc IgM, with abrupt elevation of the liver enzymes. The entire genomic sequence of HBV recovered from this patient revealed no mutations in the core promoter and precore regions that interfere with HBeAg production. A 76-year-old male with a history of endoscopic mucosal resection for esophageal cancer in 2002 and an initial diagnosis of diabetes mellitus in 2009, at which time he was negative for HBsAg. He was found to be positive for HBsAg in September 2012 during a laboratory examination performed prior to the resection of recurrent esophageal cancer, despite a low HBV load (2.1 log copies/ml). Three months later, without the administration of any anticancer drugs, the HBV DNA (genotype B) level increased to 5.1 log copies/ml. A precore G1896A variant with high quasispecies diversity was recovered from the patient. Aging, surgical stress and complication of disease(s) associated with compromised immunity, such as cancer, arteriosclerosis and diabetes mellitus may trigger spontaneous HBV reactivation.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  entire genome; hepatitis viruses; phylogenetic analysis; precore mutant

Mesh:

Substances:

Year:  2015        PMID: 25612181     DOI: 10.1002/jmv.24115

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Reactivation of resolved hepatitis B virus infection with immune escape mutations after long-term corticosteroid therapy.

Authors:  Jun Inoue; Yasuteru Kondo; Yuta Wakui; Takayuki Kogure; Tatsuki Morosawa; Yasuyuki Fujisaka; Teruyuki Umetsu; Satoshi Takai; Takuya Nakamura; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2016-02-26

2.  Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia.

Authors:  Toshihiko Ando; Kensuke Kojima; Hiroshi Isoda; Yuichiro Eguchi; Takashi Honda; Masatoshi Ishigami; Shinya Kimura
Journal:  Int J Hematol       Date:  2015-04-05       Impact factor: 2.490

3.  A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?

Authors:  Kazuhiko Hayashi; Masatoshi Ishigami; Yoji Ishizu; Teiji Kuzuya; Takashi Honda; Daisaku Nishimura; Hidemi Goto; Yoshiki Hirooka
Journal:  Clin J Gastroenterol       Date:  2016-06-21

Review 4.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

Review 5.  How I treat acute myeloid leukemia presenting with preexisting comorbidities.

Authors:  Yishai Ofran; Martin S Tallman; Jacob M Rowe
Journal:  Blood       Date:  2016-05-27       Impact factor: 22.113

6.  Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.

Authors:  Li Wang; Zhi-Qiang Zou; Kai Wang; Ji-Guang Yu; Xiang-Zhong Liu
Journal:  Hepatol Int       Date:  2015-10-01       Impact factor: 6.047

Review 7.  Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection: the differential serological diagnosis.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-18       Impact factor: 3.267

8.  Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.

Authors:  Chien-Yuan Chen; Feng-Ming Tien; Aristine Cheng; Shang-Yi Huang; Wen-Chien Chou; Ming Yao; Jih-Luh Tang; Hwei-Fang Tien; Wang-Huei Sheng
Journal:  BMC Gastroenterol       Date:  2018-01-08       Impact factor: 3.067

9.  Late Reactivation of Hepatitis B Virus after Chemotherapies for Hematological Malignancies: A Case Report and Review of the Literature.

Authors:  Toshiki Yamada; Yasuhito Nannya; Atsushi Suetsugu; Shogo Shimizu; Junichi Sugihara; Masahito Shimizu; Mitsuru Seishima; Hisashi Tsurumi
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

10.  Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs.

Authors:  Doh Hyung Kim; Seok Bae Kim
Journal:  Case Rep Gastroenterol       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.